Novel psychoactive substances (NPS), also known as “designer drugs” or “research chemicals,” present a growing threat to public health worldwide. These substances are rapidly synthesized and marketed, often without regulation, to circumvent existing drug legislation. Users may be unaware of the potential health risks associated with these